From the Research
Ivermectin may have potential as an adjunctive treatment for certain types of cancer, particularly when used in combination with other therapies, as evidenced by recent studies 1, 2, 3. The use of ivermectin in cancer treatment is still largely experimental and not widely accepted as a standard treatment option. However, some recent studies suggest that ivermectin may have anticancer effects, particularly when used in combination with other therapies. For example, a study published in 2021 found that ivermectin converted cold tumors hot and synergized with immune checkpoint blockade for treatment of breast cancer 1. Another study published in 2022 found that ivermectin augmented chemotherapy's efficacy in osteosarcoma 2. Additionally, a study published in 2022 found that the combination of ivermectin and gemcitabine induced apoptosis of pancreatic cancer cells via mitochondrial dysfunction 3. Some key points to consider when evaluating the potential use of ivermectin in cancer treatment include:
- The majority of studies on ivermectin's anticancer effects have been conducted in vitro or in animal models, and more research is needed to confirm its efficacy in human patients.
- Ivermectin may have synergistic effects when used in combination with other therapies, such as chemotherapy or immune checkpoint inhibitors.
- The optimal dosage and treatment regimen for ivermectin in cancer treatment are still unknown and require further study.
- Patients diagnosed with cancer should follow treatment plans recommended by oncologists, which typically include surgery, radiation therapy, chemotherapy, immunotherapy, or targeted therapies depending on the specific type and stage of cancer. It is essential to note that while these studies suggest potential benefits of ivermectin in cancer treatment, the evidence is still limited, and more research is needed to fully understand its effects and potential uses in this context 4, 5.